Novel tech Sorrento's SOFUSA system, in Phase Ib trial, etanercept given by transdermal nanotopography microneedles to deliver higher concentration of drugs to lymphatic system. An enbrel refractory pt treated & showed 34% improved DAS scores https://t.co/S79HUBT7rE